Global Information
회사소개 | 문의 | 비교리스트

세계의 줄기세포 치료 시장 : 예측과 기회(2025년)

Global Stem Cell Therapy Market By Type, By Source of Stem Cells, By Application, By End Users, By Region, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 934819
페이지 정보 영문 118 Pages
가격
US $ 4,450 ₩ 5,077,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,217,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,781,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 줄기세포 치료 시장 : 예측과 기회(2025년) Global Stem Cell Therapy Market By Type, By Source of Stem Cells, By Application, By End Users, By Region, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 118 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 줄기세포 치료(Stem Cell Therapy) 시장에 대해 조사 분석했으며, 시장 규모·점유율·예측, 부문별 분석, 경쟁 분석, 시장 동향 변화, 새로운 기회에 대한 체계적인 정보를 제공합니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 줄기세포 치료 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 종류별
    • 줄기세포 유래별
    • 용도별
    • 최종사용자별
    • 기업별
    • 지역별
  • 제품 시장 맵

제6장 아시아태평양의 줄기세포 치료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 아시아태평양 : 국가별 분석

제7장 유럽의 줄기세포 치료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 유럽 : 국가별 분석

제8장 북미의 줄기세포 치료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 북미 : 국가별 분석

제9장 남미의 줄기세포 치료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 남미 : 국가별 분석

제10장 중동 및 아프리카의 줄기세포 치료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 중동 및 아프리카 : 국가별 분석

제11장 시장 역학

  • 성장 촉진요인
  • 과제

제12장 시장 동향과 발전

제13장 경쟁 상황

제14장 전략적 제안

제15장 출판사와 면책사항

KSM 20.06.03

Global stem cell therapy market is expected to grow at a formidable rate of around 12% during the forecast period. The global stem cell therapy market is driven by the growing popularity and awareness pertaining to the use of stem cells for the prevention and cure of certain life threatening diseases. Additionally, increase in number of stem cell banks and growing investments by the government and private organizations for the development of stem cell preservation infrastructure is further propelling the market across the globe.

The global stem cell therapy market is segmented based on type, source of stem cells, application, end users, company and region. Based on type, the market can be categorized into allogeneic, autologous and syngeneic. The allogenic type segment is expected to register the highest growth during forecast period attributable to the rising commercialization of allogeneic stem cell therapy products, wider therapeutic applications of allogeneic stem cells, easy production scale-up process, growing number of clinical trials related to allogeneic stem cell therapies, among others. Based on end users, the market can be bifurcated into hospitals and clinics. The hospitals segment is expected to dominate the market during the forecast years. This can be accredited to the rising preference for stem cell therapies offered by hospitals proves beneficial for the business growth. Hospitals have affiliations with research laboratories and academic institutes that carry out research activities for developing stem cell therapies. On introduction and approval of any novel stem therapy, hospitals implement it immediately.

Regionally, the stem cell therapy market has been segmented into various regions namely Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate the overall stem cell therapy market during the next five years on account of the increasing number of clinical trials for stem cell-based products and increasing public-private funding & research grants.

Major players operating in the global stem cell therapy market include Osiris Therapeutics, Inc., MEDIPOST Co., Ltd., Anterogen Co., Ltd., Pharmicell Co., Ltd., Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals Co., Ltd., NuVasive, Inc., RTI Surgical, Inc., AlloSource, Thermo Fisher Scientific and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global stem cell therapy market.
  • To classify and forecast global stem cell therapy market based on type, source of stem cells, application, end users, company and regional distribution.
  • To identify drivers and challenges for global stem cell therapy market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global stem cell therapy market.
  • To identify and analyze the profile of leading players operating in global stem cell therapy market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics, end users, channels and presence of all major players across the globe.

TechSci Research calculated the market size of global stem cell therapy market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Stem Cell therapy hospitals, clinics and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to stem cell therapy
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals, clinics and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global stem cell therapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type:

Allogeneic

Autologous

Syngeneic

  • Market, By Source of Stem Cells:

Adipose Tissue

Bone Marrow

Neural

Embryo/Cord Blood Derived

iPSCs

Others

  • Market, By Application:

Musculoskeletal

Wound & Injury

Cardiovascular Disease (CVD)

Surgery

Acute Graft-Versus-Host Disease

Drug Discovery & Development

Others

  • Market, By End Users:

Hospitals

Clinics

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global stem cell therapy market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Stem Cell Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Allogeneic, Autologous, Syngeneic)
    • 5.2.2. By Source of Stem Cells (Adipose Tissue, Bone Marrow, Neural, Embryo/Cord Blood Derived, iPSCs, Others)
    • 5.2.3. By Application (Musculoskeletal, Wound & Injury, Cardiovascular Disease (CVD), Surgery, Acute Graft-Versus-Host Disease, Drug Discovery & Development, Others)
    • 5.2.4. By End Users (Hospitals v/s Clinics)
    • 5.2.5. By Company (2019)
    • 5.2.6. By Region
  • 5.3. Product Market Map

6. Asia-Pacific Stem Cell Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Source of Stem Cells
    • 6.2.3. By Application
    • 6.2.4. By End Users
    • 6.2.5. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Stem Cell Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Source of Stem Cells
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End Users
    • 6.3.2. India Stem Cell Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Source of Stem Cells
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End Users
    • 6.3.3. Australia Stem Cell Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Source of Stem Cells
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End Users
    • 6.3.4. Japan Stem Cell Therapy Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By Source of Stem Cells
        • 6.3.4.2.3. By Application
        • 6.3.4.2.4. By End Users
    • 6.3.5. South Korea Stem Cell Therapy Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By Source of Stem Cells
        • 6.3.5.2.3. By Application
        • 6.3.5.2.4. By End Users

7. Europe Stem Cell Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Source of Stem Cells
    • 7.2.3. By Application
    • 7.2.4. By End Users
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Stem Cell Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Source of Stem Cells
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End Users
    • 7.3.2. Germany Stem Cell Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Source of Stem Cells
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End Users
    • 7.3.3. United Kingdom Stem Cell Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Source of Stem Cells
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End Users
    • 7.3.4. Italy Stem Cell Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Source of Stem Cells
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End Users
    • 7.3.5. Spain Stem Cell Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Source of Stem Cells
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End Users

8. North America Stem Cell Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Source of Stem Cells
    • 8.2.3. By Application
    • 8.2.4. By End Users
    • 8.2.5. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Stem Cell Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Source of Stem Cells
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End Users
    • 8.3.2. Mexico Stem Cell Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Source of Stem Cells
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End Users
    • 8.3.3. Canada Stem Cell Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Source of Stem Cells
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End Users

9. South America Stem Cell Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Source of Stem Cells
    • 9.2.3. By Application
    • 9.2.4. By End Users
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Stem Cell Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Source of Stem Cells
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End Users
    • 9.3.2. Argentina Stem Cell Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Source of Stem Cells
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End Users
    • 9.3.3. Colombia Stem Cell Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Source of Stem Cells
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End Users

10. Middle East and Africa Stem Cell Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Source of Stem Cells
    • 10.2.3. By Application
    • 10.2.4. By End Users
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Stem Cell Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Source of Stem Cells
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End Users
    • 10.3.2. Saudi Arabia Stem Cell Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Source of Stem Cells
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End Users
    • 10.3.3. UAE Stem Cell Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Source of Stem Cells
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End Users

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Osiris Therapeutics, Inc.
  • 13.2. MEDIPOST Co., Ltd.
  • 13.3. Anterogen Co., Ltd.
  • 13.4. Pharmicell Co., Ltd.
  • 13.5. Holostem Terapie Avanzate S.r.l.
  • 13.6. JCR Pharmaceuticals Co., Ltd.
  • 13.7. NuVasive, Inc.
  • 13.8. RTI Surgical, Inc.
  • 13.9. AlloSource
  • 13.10. Thermo Fisher Scientific

14. Strategic Recommendations

15. About Us & Disclaimer

Back to Top
전화 문의
F A Q